Product News

Share this article:

Wyeth received FDA approval for a new indication on Tygacil, a pneumonia drug. The additional indication was approved for adult patients with community-acquired bacterial pneumonia.

 

A New York federal judge has asked the FDA to make Plan B, an emergency contraceptive, available to 17-year-olds within 30 days. US District Judge Edward Korman also asked the agency to review whether to make the product available for girls of all ages, without a prescription. Plan B is manufactured by Barr Pharmaceuticals, a division of Teva Pharmaceuticals.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions